Production and characterization of poly lactic-co-glycolic acid particles containing anti-inflammatory substances for skin lesion recovery
- 9 July 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 35 (4-5) , 414-425
Abstract
Poly lactic-co-glycolic acid particles are biodegradable and biocompatible drug delivery systems that provide a controlled release of drugs in specific sites. These characteristics minimize the occurrence of side effects related to overdosing. To overcome the issues associated with the conservative treatment for wound healing, the objective of this work was to develop a poly lactic-co-glycolic acid particles system to deliver anti-inflammatory compounds (epigallocatechin gallate and asiaticoside) to fibroblasts. Nanoscale (~200 nm) and microscale (~10 µm) poly lactic-co-glycolic acid particles were produced using two different protocols. Nanoscale particles reduced cell proliferation by 46% compared with untreated human skin fibroblasts, whereas microscale particles did not affect fibroblast viability significantly. The toxicity of nanoparticles and the nontoxic nature of microparticles were confirmed in live and dead cell staining experiments. In vitro drug release assays showed that particles containing epigallocatechin gallate and asiaticoside were able to release most of their payload during the first 8 h of incubation. The treatment of lipopolysaccharide-stimulated fibroblasts with epigallocatechin gallate- and asiaticoside-loaded microparticles effectively suppressed the expression of inflammatory factors: tumor necrosis factor-α, interleukin-1β, and interleukin-6. In this study, we found that the optimal size of biodegradable poly lactic-co-glycolic acid particles for the delivery of physiologically active substances to fibroblasts is about 10 μm. Moreover, our findings indicate that poly lactic-co-glycolic acid particles of this size can be effectively applied to ameliorate tissue regeneration by delivering physiologically active substances to improve skin lesion recovery.Keywords
This publication has 21 references indexed in Scilit:
- Tea Polyphenols for Skin CareResearch Journal of Topical and Cosmetic Sciences, 2015
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applicationsBiochemical Pharmacology, 2011
- Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitroCancer Prevention Research, 2009
- Involvement of Notch Signaling in Wound HealingPLOS ONE, 2007
- Recombinant Human Epidermal Growth Factor (EGF) to Enhance Healing for Diabetic Foot UlcersAnnals of Plastic Surgery, 2006
- Antiviral effect of catechins in green tea on influenza virusAntiviral Research, 2005
- In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiaticaJournal of Ethnopharmacology, 1999
- Application of Central Composite Designs to the Preparation of Polycaprolactone Nanoparticles by Solvent DisplacementJournal of Pharmaceutical Sciences, 1996
- Indomethacin-loaded poly (d,l-lactide) nanocapsules protection from gastrointestinal ulcerations and anti-inflammatory activity evaluation in ratsClinical Materials, 1993
- Design of an artificial skin. II. Control of chemical compositionJournal of Biomedical Materials Research, 1980